See the DrugPatentWatch profile for ozempic

Ozempic, also known as semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist used to regulate blood sugar levels in adults with type 2 diabetes. It mimics the functions of natural GLP-1 hormones in the body, which are responsible for regulating blood sugar levels and insulin production [1].

Ozempic works by increasing insulin secretion in response to elevated blood sugar levels, reducing glucagon secretion, slowing gastric emptying, and promoting satiety, leading to improved glycemic control [2]. By slowing gastric emptying, Ozempic helps to reduce postprandial glucose levels and improves overall glucose control [3].

Moreover, Ozempic has been shown to have a positive impact on weight management, with clinical trials demonstrating an average weight loss of 4.5-6.5 kg over a 26-40 week period [4].

It is important to note that Ozempic is not a substitute for insulin and should be used in conjunction with a healthy diet and exercise regimen [5].

In summary, Ozempic regulates blood sugar levels by mimicking the functions of natural GLP-1 hormones, increasing insulin secretion, reducing glucagon secretion, slowing gastric emptying, and promoting satiety.

Sources:
[1] "Ozempic (semaglutide) injection, for subcutaneous use." DailyMed, <https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=48d3d3a6-8e3e-4e1e-a8f4-8f8b5e1e5f0a&type=display>.
[2] "Semaglutide." Drugs.com, <https://www.drugs.com/mtm/semaglutide.html>.
[3] "Ozempic." Diabetes.co.uk, <https://www.diabetes.co.uk/diabetes-medication/ozempic.html>.
[4] "Ozempic (semaglutide) for type 2 diabetes." DrugPatentWatch, <https://www.drugpatentwatch.com/drugs/ozempic>.
[5] "Ozempic." Novo Nordisk, <https://www.novonordisk-us.com/patient/products/ozempic.html>.